Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2022 Earnings Call Transcript November 12, 2022
Operator: Good afternoon. My name is Kathy, and I’ll be your conference operator for today. At this time, I would like to welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2022 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. And Brian Ritchie, you may begin your conference.
Brian...
